ANTHONY PUSATERI: Open Payments
NPI 1568129138 · DANVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,189 in 98 payments from 13 companies in 2025. Trend: 2023 $101 · 2024 $795 · 2025 $1,189
Food & beverage: $1,189
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 33 | $295 |
| Janssen Pharmaceuticals, Inc | 15 | $182 |
| Neurocrine BioSciences, Inc. | 19 | $181 |
| Lundbeck LLC | 12 | $168 |
| Otsuka America Pharmaceutical, Inc. | 4 | $86 |
| Alkermes, Inc. | 3 | $70 |
| ABBVIE INC. | 3 | $47 |
| Almatica Pharma LLC | 2 | $39 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Supernus Pharmaceuticals, Inc. | 2 | $30 |
Products named: REXULTI, UZEDY, INGREZZA, INVEGA SUSTENNA, ARISTADA, SPRAVATO, VRAYLAR, AUSTEDO XR.
Industry payments across PA — which companies pay providers there.
